Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of

G S Dveksler1, M N Pensiero, C W Dieffenbach

  • 1Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799.

Insights

Mouse hepatitis virus (MHV) uses carcinoembryonic antigen family proteins as cellular receptors. The N-terminal domain of the MHV receptor is crucial for viral binding and infection, as identified through recombinant protein studies.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Mouse hepatitis virus (MHV) strain A59 infection relies on cellular receptors from the carcinoembryonic antigen (CEA) family within the immunoglobulin superfamily.
  • Understanding the specific domains of these receptors involved in viral interaction is key to developing antiviral strategies.

Purpose of the Study:

  • To identify the precise regions of the MHV receptor glycoprotein recognized by the virus and a blocking monoclonal antibody (CC1).
  • To determine the essential domains for functional virus receptor activity.

Main Methods:

  • Utilized recombinant receptor proteins with deletions in immunoglobulin domains.
  • Transfected receptor-negative hamster cells with these recombinant clones.
  • Assessed viral binding and infection following MHV-A59 challenge.

Main Results:

  • Both MHV-A59 virions and monoclonal antibody CC1 specifically bound to recombinant receptors containing the complete first domain.
  • Functional receptor activity required the N-terminal domain, along with either the second or fourth domain, and transmembrane/cytoplasmic domains.
  • Recombinant proteins lacking the first domain or its C-terminal portion failed to mediate viral entry.

Conclusions:

  • The N-terminal domain of the MHV receptor is recognized by both the virus and blocking antibodies, similar to other immunoglobulin superfamily receptors.
  • This domain is essential for MHV binding and subsequent cellular infection.